Mirtazapine improves caloric intake compared to placebo in patients with advanced non-small cell lung cancer

1. While perceived appetite did not differ between study groups, patients receiving mirtazapine had significantly increased caloric consumption compared with the placebo group. 2. Mirtazapine is well-tolerated, with nightmares being one of the primary significant adverse events, but the difference was insignificant at both the 4- and 8-week follow-up points. Evidence Rating Level: 1 (Excellent) […]

The post Mirtazapine improves caloric intake compared to placebo in patients with advanced non-small cell lung cancer first appeared on 2 Minute Medicine.